The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Vascular endothelial growth factor (VEGF) and its receptors
Abstract
Vascular endothelial growth factor (VEGF) is a highly specific mitogen for vascular endothelial cells. Five VEGF isoforms are generated as a result of alternative splicing from a single VEGF gene. These isoforms differ in their molecular mass and in biological properties such as their ability to bind to cell‐surface heparan‐sulfate proteoglycans. The expression of VEGF is potentiated in response to hypoxia, by activated oncogenes, and by a variety of cytokines. VEGF induces endothelial cell proliferation, promotes cell migration, and inhibits apoptosis. In vivo VEGF induces angiogenesis as well as permeabilization of blood vessels, and plays a central role in the regulation of vasculogenesis. Deregulated VEGF expression contributes to the development of solid tumors by promoting tumor angiogenesis and to the etiology of several additional diseases that are characterized by abnormal angiogenesis. Consequently, inhibition of VEGF signaling abrogates the development of a wide variety of tumors. The various VEGF forms bind to two tyrosine‐kinase receptors, VEGFR‐1 ( flt‐1 ) and VEGFR‐2 ( KDR/flk‐1) , which are expressed almost exclusively in endothelial cells. Endothelial cells express in addition the neuropilin‐1 and neuropilin‐2 coreceptors, which bind selectively to the 165 amino acid form of VEGF (VEGF 165 ). This review focuses on recent developments that have widened considerably our understanding of the mechanisms that control VEGF production and VEGF signal transduction and on recent studies that have shed light on the mechanisms by which VEGF regulates angiogenesis.—Neufeld, G., Cohen, T., Gengrinovitch, S., Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9–22 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Research works printed but not linked: 6
- 10.1210/endo.133.2.7688292 · doi:10.1210/endo.133.2.7688292 · Paper page
- 10.1097/01.iae.0000246884.76018.63 · DOI · Paper page
- 10.1210/endo.137.6.8641174 · doi:10.1210/endo.137.6.8641174 · Paper page
- 10.1006/bbrc.1996.0730 · doi:10.1006/bbrc.1996.0730
- Fournier E., 1997, Receptors for factors of the VEGF family, Bull. Cancer, 84, 397
- 10.1006/bbrc.1995.1492 · doi:10.1006/bbrc.1995.1492
Cited by
Items 101–200 of 240
Gluzman-Poltorak, Z., Cohen, T., Herzog, Y., & Neufeld, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909259199 · Cited by 407
Self-citationVEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification
Dai, J., & Rabie, A. B. M. (2007) · Journal of Dental Research · doi:10.1177/154405910708601006 · Cited by 404
Gene transfer as a tool to induce therapeutic vascular growth
Ylä-Herttuala, S., & Alitalo, K. (2003) · Nature Medicine · doi:10.1038/nm0603-694 · Cited by 404
Development of the Primate Retinal Vasculature
Provis, J. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00012-x · Cited by 402
Deroanne, C. F., Bonjean, K., Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J.-M., Nusgens, B. V., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205108 · Cited by 400
“…e ect of TSA on the phenotype of HUVEC was further evaluated by measuring the steady-state level of the mRNAs coding for the VEGF receptors, VEGFR1, its soluble form sVEGFR1, VEGFR2 (Neufeld et al., 1999), and the recently identi®ed co-receptor for VEGF165, neuropilin-1 (Miao et al., 1999).”
BackgroundInfluentialCurrent Concepts in the Etiology and Treatment of Behçet Disease
Evereklioglu, C. (2005) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2005.04.009 · Cited by 393
Bioactive Glass Stimulates the Secretion of Angiogenic Growth Factors and Angiogenesis in Vitro
Day, R. M. (2005) · Tissue Engineering · doi:10.1089/ten.2005.11.768 · Cited by 389
Skobe, M., Hamberg, L. M., Hawighorst, T., Schirner, M., Wolf, G. L., Alitalo, K., & Detmar, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61765-8 · Cited by 388
Understanding the biology of angiogenesis: Review of the most important molecular mechanisms
Otrock, Z. K., Mahfouz, R. A. R., Makarem, J. A., & Shamseddine, A. I. (2007) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2007.04.001 · Cited by 386
Karamysheva, A. F. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908070031 · Cited by 386
Colavitti, R., Pani, G., Bedogni, B., Anzevino, R., Borrello, S., Waltenberger, J., & Galeotti, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107711200 · Cited by 384
Ischemic rat brain extracts induce human marrow stromal cell growth factor production
Chen, X., Li, Y., Wang, L., Katakowski, M., Zhang, L., Chen, J., Xu, Y., Gautam, S. C., & Chopp, M. (2002) · Neuropathology · doi:10.1046/j.1440-1789.2002.00450.x · Cited by 382
VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells
Salven, P., Mustjoki, S., Alitalo, R., Alitalo, K., & Rafii, S. (2003) · Blood · doi:10.1182/blood-2002-03-0755 · Cited by 377
Vascular endothelial growth factor family of ligands and receptors: Review
Otrock, Z. K., Makarem, J. A., & Shamseddine, A. I. (2007) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2006.12.003 · Cited by 376
Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions
Tumova, S., Woods, A., & Couchman, J. R. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00116-8 · Cited by 375
Ylä-Herttuala, S., & Martin, J. F. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04180-x · Cited by 375
VEGF: an update on biological and therapeutic aspects
Ferrara, N. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00153-1 · Cited by 372
Inoki, I., Shiomi, T., Hashimoto, G., Enomoto, H., Nakamura, H., Makino, K.-I., Ikeda, E., Takata, S., Kobayashi, K.-I., & Okada, Y. (2002) · The FASEB Journal · doi:10.1096/fj.01-0332fje · Cited by 372
VEGF as a Mediator of Tumor-Associated Immunodeficiency
Ohm, J. E., & Carbone, D. P. (2001) · Immunologic Research · doi:10.1385/ir:23:2-3:263 · Cited by 371
Sondell, M., Sundler, F., & Kanje, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01326.x · Cited by 370
Role of Redox Signaling in Neuroinflammation and Neurodegenerative Diseases
Hsieh, H.-L., & Yang, C.-M. (2013) · BioMed Research International · doi:10.1155/2013/484613 · Cited by 365
Dimmeler, S., Dernbach, E., & Zeiher, A. M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01657-4 · Cited by 364
Mathematical modeling of tumor-induced angiogenesis
Mantzaris, N. V., Webb, S., & Othmer, H. G. (2004) · Journal of Mathematical Biology · doi:10.1007/s00285-003-0262-2 · Cited by 362
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms
Stalmans, I., Ng, Y.-S., Rohan, R., Fruttiger, M., Bouché, A., Ÿuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214362 · Cited by 358
Autiero, M., Luttun, A., Tjwa, M., & Carmeliet, P. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00263.x · Cited by 357
Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation
KOFLER, S., NICKEL, T., & WEIS, M. (2005) · Clinical Science · doi:10.1042/cs20040174 · Cited by 353
Weis, S., Shintani, S., Weber, A., Kirchmair, R., Wood, M., Cravens, A., McSharry, H., Iwakura, A., Yoon, Y.-S., Himes, N., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420702 · Cited by 353
Schrijvers, B. F., De Vriese, A. S., & Flyvbjerg, A. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0018 · Cited by 353
Neufeld, G. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00140-2 · Cited by 350
Self-citationWang, J., Li, D., Cang, H., & Guo, B. (2019) · Cancer Medicine · doi:10.1002/cam4.2327 · Cited by 349
Vascular Endothelial Growth Factor in Porcine-Derived Extracellular Matrix
Hodde, J. P., Record, R. D., Liang, H. A., & Badylak, S. F. (2001) · Endothelium · doi:10.3109/10623320109063154 · Cited by 348
Molecular basis of angiogenesis and cancer
Tonini, T., Rossi, F., & Claudio, P. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206816 · Cited by 347
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
Strizzi, L., Catalano, A., Vianale, G., Orecchia, S., Casalini, A., Tassi, G., Puntoni, R., Mutti, L., & Procopio, A. (2001) · The Journal of Pathology · doi:10.1002/path.824 · Cited by 346
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
Podar, K., & Anderson, K. C. (2005) · Blood · doi:10.1182/blood-2004-07-2909 · Cited by 343
The molecular profile of microglia under the influence of glioma
Li, W., & Graeber, M. B. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos116 · Cited by 340
Nowak, D. G., Woolard, J., Amin, E. M., Konopatskaya, O., Saleem, M. A., Churchill, A. J., Ladomery, M. R., Harper, S. J., & Bates, D. O. (2008) · Journal of Cell Science · doi:10.1242/jcs.016410 · Cited by 339
Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2
Zelzer, E., Glotzer, D. J., Hartmann, C., Thomas, D., Fukai, N., Soker, S., & Olsen, B. R. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00428-2 · Cited by 339
Growth factors in the treatment of diabetic foot ulcers
Bennett, S. P., Griffiths, G. D., Schor, A. M., Leese, G. P., & Schor, S. L. (2003) · British Journal of Surgery · doi:10.1002/bjs.4019 · Cited by 338
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
Wang, D., Wang, H., Brown, J., Daikoku, T., Ning, W., Shi, Q., Richmond, A., Strieter, R., Dey, S. K., & DuBois, R. N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052124 · Cited by 338
Hyperoxia causes angiopoietin 2–mediated acute lung injury and necrotic cell death
Bhandari, V., Choo-Wing, R., Lee, C. G., Zhu, Z., Nedrelow, J. H., Chupp, G. L., Zhang, X., Matthay, M. A., Ware, L. B., Homer, R. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1494 · Cited by 337
The ephrins and Eph receptors in angiogenesis
Cheng, N., Brantley, D. M., & Chen, J. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00031-4 · Cited by 334
Tran, J., Rak, J., Sheehan, C., Saibil, S. D., LaCasse, E., Korneluk, R. G., & Kerbel, R. S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1589 · Cited by 333
Current Concepts in the Etiology and Treatment of Behçet Disease
Androudi, S. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2005.12.006 · Cited by 333
Mahlapuu, M., Ormestad, M., Enerbäck, S., & Carlsson, P. (2001) · Development · doi:10.1242/dev.128.2.155 · Cited by 332
Bremnes, R. M., Camps, C., & Sirera, R. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2005.09.005 · Cited by 330
Osteopenia and decreased bone formation in osteonectin-deficient mice
Delany, A. M., Amling, M., Priemel, M., Howe, C., Baron, R., & Canalis, E. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7039 · Cited by 330
von Marschall, Z., Scholz, A., Cramer, T., Schafer, G., Schirner, M., Oberg, K., Wiedenmann, B., Hocker, M., & Rosewicz, S. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.437 · Cited by 328
VEGF-A: a critical regulator of blood vessel growth
Ferrara, N. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0170 · Cited by 327
Mayer, H., Bertram, H., Lindenmaier, W., Korff, T., Weber, H., & Weich, H. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20462 · Cited by 324
Modeling the early stages of vascular network assembly
Serini, G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg176 · Cited by 322
Pitfalls in the Measurement of Circulating Vascular Endothelial Growth Factor
Jelkmann, W. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.617 · Cited by 322
Fredberg, U., & Stengaard‐Pedersen, K. (2008) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2007.00746.x · Cited by 322
Duman, R. S., Deyama, S., & Fogaça, M. V. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14630 · Cited by 321
Impact of oxidative stress on lung diseases
PARK, H. S., KIM, S. R., & LEE, Y. C. (2009) · Respirology · doi:10.1111/j.1440-1843.2008.01447.x · Cited by 321
Rakic, J.-M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J.-M., Noe¨l, A., & Munaut, C. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1092 · Cited by 321
Traxler, P., Allegrini, P. R., Brandt, R., Brueggen, J., Cozens, R., Fabbro, D., Grosios, K., Lane, H. A., McSheehy, P., Mestan, J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3681 · Cited by 320
Konecny, G. E., Meng, Y. G., Untch, M., Wang, H.-J., Bauerfeind, I., Epstein, M., Stieber, P., Vernes, J.-M., Gutierrez, J., Hong, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0951-3 · Cited by 318
A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis
Kollmann, K., Heller, G., Schneckenleithner, C., Warsch, W., Scheicher, R., Ott, R. G., Schäfer, M., Fajmann, S., Schlederer, M., Schiefer, A.-I., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.012 · Cited by 313
“Transcriptional Regulation of Vegf-A by CDK6 Because tumor angiogenesis is frequently driven by ligands of the vascular endothelial growth factor (VEGF) receptor, we investigated the levels of the most prominent growth factor VEGF-A (Ferrara and Davis-Smyth, 1997; Neufeld et al., 1999).”
BackgroundDistler, O., Distler, J. H. W., Scheid, A., Acker, T., Hirth, A., Rethage, J., Michel, B. A., Gay, R. E., Müller-Ladner, U., Matucci-Cerinic, M., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000134644.89917.96 · Cited by 310
Gagnon, M. L., Bielenberg, D. R., Gechtman, Z., Miao, H.-Q., Takashima, S., Soker, S., & Klagsbrun, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040337597 · Cited by 313
Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression
Miao, H., Lee, P., Lin, H., Soker, S., & Klagsbrun, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0250com · Cited by 312
Flyvbjerg, A., Dagnæs-Hansen, F., De Vriese, A. S., Schrijvers, B. F., Tilton, R. G., & Rasch, R. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3090 · Cited by 309
Amant, F., Mirza, M. R., & Creutzberg, C. L. (2012) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(12)60024-1 · Cited by 309
Hybrid Multicomponent Hydrogels for Tissue Engineering
Jia, X., & Kiick, K. L. (2009) · Macromolecular Bioscience · doi:10.1002/mabi.200800284 · Cited by 308
Hypoxia-ischemia and retinal ganglion cell damage
Kaur, C. (2008) · Clinical Ophthalmology · doi:10.2147/opth.s3361 · Cited by 308
Brain Extracellular Matrix in Neurodegeneration
Bonneh‐Barkay, D., & Wiley, C. A. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00195.x · Cited by 307
Angiogenesis in the Corpus Luteum
Reynolds, L. P., Grazul-Bilska, A. T., & Redmer, D. A. (2000) · Endocrine · doi:10.1385/endo:12:1:1 · Cited by 306
Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor
Zachary, I. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1375 · Cited by 301
Unique Structural Features That Influence Neutrophil Emigration Into the Lung
Burns, A. R., Smith, C. W., & Walker, D. C. (2003) · Physiological Reviews · doi:10.1152/physrev.00023.2002 · Cited by 297
Basile, D. P., Friedrich, J. L., Spahic, J., Knipe, N., Mang, H., Leonard, E. C., Changizi-Ashtiyani, S., Bacallao, R. L., Molitoris, B. A., & Sutton, T. A. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00546.2010 · Cited by 296
Effect of nutrient intake during pregnancy on fetal and placental growth and vascular development
Redmer, D. A., Wallace, J. M., & Reynolds, L. P. (2004) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2004.06.006 · Cited by 294
Whitaker, G. B., Limberg, B. J., & Rosenbaum, J. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102315200 · Cited by 294
Shen, Y. H., Shoichet, M. S., & Radisic, M. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2007.12.011 · Cited by 289
Regulation of angiogenesis by extracellular matrix
Sottile, J. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.07.002 · Cited by 288
Polysaccharide‐modified synthetic polymeric biomaterials
Baldwin, A. D., & Kiick, K. L. (2010) · Peptide Science · doi:10.1002/bip.21334 · Cited by 287
Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain
Hamilton, J. L., Nagao, M., Levine, B. R., Chen, D., Olsen, B. R., & Im, H.-J. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2828 · Cited by 287
Shen, B.-Q., Lee, D. Y., & Zioncheck, T. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33057 · Cited by 286
Regulation of Endothelial Cell Survival and Apoptosis During Angiogenesis
Chavakis, E., & Dimmeler, S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000017728.55907.a9 · Cited by 285
Bussolati, B., Dunk, C., Grohman, M., Kontos, C. D., Mason, J., & Ahmed, A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61775-0 · Cited by 284
Single-cell analysis of the cellular heterogeneity and interactions in the injured mouse spinal cord
Milich, L. M., Choi, J. S., Ryan, C., Cerqueira, S. R., Benavides, S., Yahn, S. L., Tsoulfas, P., & Lee, J. K. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20210040 · Cited by 283
Wick, A., Wick, W., Waltenberger, J., Weller, M., Dichgans, J., & Schulz, J. B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06401.2002 · Cited by 283
Signaling via Vascular Endothelial Growth Factor Receptors
Petrova, T. V., Makinen, T., & Alitalo, K. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4707 · Cited by 277
Vascular endothelial growth factor can signal through platelet-derived growth factor receptors
Ball, S. G., Shuttleworth, C. A., & Kielty, C. M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200608093 · Cited by 276
Bhutto, I. A., McLeod, D. S., Hasegawa, T., Kim, S. Y., Merges, C., Tong, P., & Lutty, G. A. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.05.007 · Cited by 275
Roboz, G. J., Dias, S., Lam, G., Lane, W. J., Soignet, S. L., Warrell, R. P., & Rafii, S. (2000) · Blood · doi:10.1182/blood.v96.4.1525 · Cited by 275
EGR2 Mutations in Inherited Neuropathies Dominant-Negatively Inhibit Myelin Gene Expression
Nagarajan, R., Svaren, J., Le, N., Araki, T., Watson, M., & Milbrandt, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00282-3 · Cited by 273
Mayerhofer, M., Valent, P., Sperr, W. R., Griffin, J. D., & Sillaber, C. (2002) · Blood · doi:10.1182/blood-2002-01-0109 · Cited by 273
Matsuzaki, H., Tamatani, M., Yamaguchi, A., Namikawa, K., Kiyama, H., Vitek, M. P., Mitsuda, N., & Tohyama, M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0495fje · Cited by 271
Ogunshola, O. O., Antic, A., Donoghue, M. J., Fan, S.-Y., Kim, H., Stewart, W. B., Madri, J. A., & Ment, L. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111085200 · Cited by 268
Rosen, L. S. (2002) · Cancer Control · doi:10.1177/107327480200902s05 · Cited by 268
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
Zhao, D., Pan, C., Sun, J., Gilbert, C., Drews-Elger, K., Azzam, D. J., Picon-Ruiz, M., Kim, M., Ullmer, W., El-Ashry, D., et al. (2015) · Oncogene · doi:10.1038/onc.2014.257 · Cited by 267
Developmental and adult phenotyping directly from mutant embryonic stem cells
George, S. H. L., Gertsenstein, M., Vintersten, K., Korets-Smith, E., Murphy, J., Stevens, M. E., Haigh, J. J., & Nagy, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609277104 · Cited by 266
Zachary, I. (2005) · Neurosignals · doi:10.1159/000088637 · Cited by 266
Molecular Basis of Angiogenesis: Role of VEGF and VE‐Cadherin
CARMELIET, P., & COLLEN, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06320.x · Cited by 264
Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
Saaristo, A., Karpanen, T., & Alitalo, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203969 · Cited by 264
SDF-1 is both necessary and sufficient to promote proliferative retinopathy
Butler, J. M., Guthrie, S. M., Koc, M., Afzal, A., Caballero, S., Brooks, H. L., Mames, R. N., Segal, M. S., Grant, M. B., & Scott, E. W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522869 · Cited by 263
ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165
Luque, A., Carpizo, D. R., & Iruela-Arispe, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212964200 · Cited by 263
Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma
Francescone, R. A., Scully, S., Faibish, M., Taylor, S. L., Oh, D., Moral, L., Yan, W., Bentley, B., & Shao, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212514 · Cited by 261
Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta
Jena, M. K., Sharma, N. R., Petitt, M., Maulik, D., & Nayak, N. R. (2020) · Biomolecules · doi:10.3390/biom10060953 · Cited by 261
Active Hair Growth (Anagen) is Associated with Angiogenesis
Mecklenburg, L., Tobin, D. J., Müller-Röver, S., Handjiski, B., Wendt, G., Peters, E. M. J., Pohl, S., Moll, I., & Paus, R. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00954.x · Cited by 260
Metadata
- Authors
- NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-01
- Volume
- 13
- Issue
- 1
- Pages
- 9-22
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2141046053
- Cited by
- 3,483
- References
- 180
- FWCI
- 67.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Israel Academy of Sciences and Humanities
- Israel Cancer Research Fund
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.